Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis
Sign Up to like & getrecommendations! Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0219855
Abstract: Aim Cystic fibrosis (CF) patients are at high risk of developing CF-related diabetes (CFRD). In non-CF patients, liver disease, specifically steatosis and non-alcoholic fatty liver disease (NAFLD), is strongly associated with type 2 diabetes. We… read more here.
Keywords: cystic fibrosis; enzyme alt; alt levels; alt ... See more keywords